[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1849 

# __Lack of effective treatment__

## Category to which it belongs

* [Inadequate resources, staff, facilities, training, coordination, and preparedness contribute to the inefficient and ineffective response to various challenges and needs.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_28.md)

## Closest similar item

* [Lack of treatment and resources](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2046.md)
* [Lack of novel treatment options](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2165.md)
* [Lack of effective drugs](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2684.md)
* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1139.md)
* [Lack of effective pharmaceutical response](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1589.md)
* [Ineffective non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1478.md)
* [Insufficient non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1590.md)
* [Inadequate healthcare response](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_515.md)
* [Lack of vaccine or cure](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1733.md)
* [Ineffective treatments based on flawed preprints](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_617.md)

## Description of the risk

There are no specific medicines or vaccines available to control or treat COVID-19.

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Is the risk affecting GBN scales

* [No](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Scale_0.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Impact_2.md)

## Mitigations of this risk

* [Support ongoing research for vaccine development and antiviral medications, repurpose existing drugs for treatment](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2454.md)

## Name of the risk

Increased severity and mortality rates

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)

## Articles mentionning the risk

* [Nurture to nature via COVID-19, a self-regenerating environmental strategy of environment in global context](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_44.md)

## People affected by this risk

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)
* [Individuals infected with covid-19](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_684.md)

## Technologies linked to the risk

* [Research and development of vaccines](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1235.md)

## Property: has_RiskType

* [Health](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_4.md)
* [Technological](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_5.md)

